Keyphrases
18F-fluorodeoxyglucose (18F-FDG)
18%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
26%
5-year Outcomes
17%
64Cu-DOTATATE
17%
Acute Myocardial Infarction
87%
Acute ST-elevation Myocardial Infarction
17%
Bone Marrow Cells
30%
Carotid Artery
16%
Chronic Ischemic Heart Disease
39%
Clinical Outcomes
20%
Familial Adenomatous Polyposis
17%
Gene Expression
18%
Granulocyte Colony-stimulating Factor (G-CSF)
100%
HIV Patients
17%
Infarct Size
15%
Intramyocardial Injection
30%
Ischemia
27%
Left Ventricular Ejection Fraction
18%
Left Ventricular Function
33%
Magnetic Resonance Imaging
31%
Molecular Imaging
16%
Myocardial Flow Reserve
17%
Myocardial Function
17%
Myocardial Infarction
67%
Myocardial Recovery
26%
Myocardial Regeneration
17%
PET-MRI
30%
Positron Emission Tomography
57%
Positron Emission Tomography-computed Tomography (PET-CT)
17%
Primary Percutaneous Coronary Intervention
16%
Reperfusion Therapy
17%
Rubidium-82
35%
ST-elevation Myocardial Infarction (STEMI)
46%
Stable Coronary Artery Disease
27%
Stem Cell Mobilization
37%
Stem Cells
44%
YKL-40
35%
Medicine and Dentistry
Acute Heart Infarction
65%
Atherosclerosis
58%
Copper 64
17%
Fluorodeoxyglucose F 18
26%
Gene Expression
20%
Granulocyte Colony Stimulating Factor
79%
Heart Left Ventricle Ejection Fraction
15%
Heart Left Ventricle Function
16%
Heart Muscle Perfusion
23%
Hematopoietic Cell
22%
Human immunodeficiency virus
35%
Infarction
23%
Ischemia
15%
Ischemic Heart Disease
44%
Magnetic Resonance Imaging
39%
Magnetic Resonance Imaging
17%
Mesenchymal Stem Cell
17%
Myocardial Infarction
55%
Neointimal Hyperplasia
17%
Percutaneous Coronary Intervention
15%
Polyethylene Terephthalate
35%
positron emission tomographic scan
76%
Primary Percutaneous Coronary Intervention
18%
Rubidium 82
27%
ST Elevation
20%
ST Segment Elevation Myocardial Infarction
47%
Stem Cell
35%
Stem Cell Mobilization
20%
